Effects of UCP2 –866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes

AIMS: The aim of this study was to explore the impact of UCP2 and ADRB3 genetic polymorphisms on the therapeutic efficacy of rosiglitazone in Chinese Type 2 diabetes (T2DM) patients. METHODS: A total of 199 T2DM patients and 155 healthy volunteers were enrolled to identify UCP2 –866 G/A genotypes, a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yang, Min, Huang, Qiong, Wu, Jing, Yin, Ji-Ye, Sun, Hong, Liu, Hai-Ling, Zhou, Hong-Hao, Liu, Zhao-Qian
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2009
Teme:
Clinical Trials
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732936/
https://ncbi.nlm.nih.gov/pubmed/19659999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03431.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items